Overall rank by patents
#49,011
of 49,997 tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 2 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: F41A (Functional Features OR Details Common TO Both Smallarms AND Ordnance, e.g. CANNONS; Mountings FOR Smallarms OR Ordnance).
The verdict
According to USPTO PatentsView, Nemo ranks #49,011 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 2 technology areas.
USPTO PatentsView assignee plate
Corpus R49011 · US Corporation #49,011 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL
Nearest grant-volume peer: Needstomatch Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Grifols Therapeutics · near
24 score
Picote Solutions · near
24 score
Bluebonnet Foods · near
24 score
Nemo Arms · this assignee
24 score
Tianjin Bytedance… · near
24 score
3D Lighting… · lowest
7 score
What this shows Nemo's Innovation Score is 23.6/100 (12th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Nemo Arms, Inc. is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under F41A (Functional Features OR Details Common TO Both Smallarms AND Ordnance, e.g. CANNONS; Mountings FOR Smallarms OR Ordnance). Peak complete grant year is 2019 (2 grants) versus a trough of 1 in 2015. By volume, Nemo sits between Needstomatch Corporation and Nepa Gene Co., Ltd..
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Needstomatch Corporation
5 patents
Nefab AB
5 patents
Nektium Pharma S.L.
5 patents
Nellone Therapeutics, Inc.
5 patents
NEO G Limited
5 patents
Neosurgical Limited
5 patents
Neovasc Medical Ltd.
5 patents
Nepa Gene Co., Ltd.
5 patents
Nemo Arms, Inc.
5 patents
What this shows Nemo holds 5 patents at rank #48,986, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #48,986 in granted patent volume.
Other assignees with the most granted patents in Nemo's primary technology class.
Two PlainPatent-derived peer sets for Nemo, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (24 here).
Nemo's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
24 12th percentile higher than 12% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 20.0% |
| 2019 | 2 | 40.0% |
| 2020 | 1 | 20.0% |
| 2021 | 1 | 20.0% |
Top 2 of 2 technology areas
Overall rank by patents
#49,011
of 49,997 tracked assignees
23.6 out of 100
What to do with this data
Nemo Arms, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.